High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: Results from the LURIC Study

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 6, 2011, Pages 1053-1058

  Ivandic, Boris T ^a,b,c   Spanuth, Eberhard ^b   Kleber, Marcus ^a   Grammer, Tanja B ^a,d   März, Winfried ^a,c,d  

^a SYNLAB ACADEMY   (Germany)

^b DIAneering Diagnostics Engineering and Research GmbH   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

myocardial infarction; natriuretic peptide; risk factor; troponin

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TROPONIN T;

AGED; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; THORAX PAIN; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK; TROPONIN T;

EID: 79958259643     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.176     Document Type: Article

References (12)

1. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:254-61.
2. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Hartwiger S, Biedert S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;361: 858-67.
3. Beyrau R, Braun S, Dolci A, Freidank H, Giannitsis E, Handy B, et al. Multicentre evaluation of a high-sensitive Elecsys® troponin T assay [abstract]. AACC 2009, Presentation 09-A-1021-AACC.
4. Omland T. New features of troponin testing in different clinical settings. J Intern Med 2010;268:207-17.
5. Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009;361: 2538-47.
6. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide predicts long-terms mortality in stable coronary heart disease. N Engl J Med 2005; 352:666-75. (Pubitemid 40239214)
7. Omland T. B-types natriuretic peptides: prognostic markers in stable coronary artery disease. Expert Rev Mol Diagn 2008;8: 217-25. (Pubitemid 351469441)
8. Maerz W, Tiran B, Seelhorst U, Wellnitz B, Bauersachs J, Winkelmann BR, et al. N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen risk and cardiovascular health study. Clin Chem 2007;53:1075-83. (Pubitemid 46867524)
9. Winkelmann BR, Marz W, Boehm BO, Zotz R, Hager J, Hellstern P, et al. Rationale and design of the LURIC study: a resource for functional genomics, pharmacogenomis, and long-term prognosis of cardiovascular disease. Pharmacogenomics 2001;2:S1-73.
10. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-87. (Pubitemid 26072233)
11. Cook NR. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem 2008;54:17-23. (Pubitemid 351182592)
12. Pencina MJ, D'Agostino RB, D'Agostino BJ, Vasan RS. Evaluating the added predictive ability of a new biomarker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-72. (Pubitemid 351193639)